BG62756B1 - Метод за лечение на андрогенна алопеция с инхибитори на 5-алфа редуктаза - Google Patents

Метод за лечение на андрогенна алопеция с инхибитори на 5-алфа редуктаза Download PDF

Info

Publication number
BG62756B1
BG62756B1 BG100510A BG10051096A BG62756B1 BG 62756 B1 BG62756 B1 BG 62756B1 BG 100510 A BG100510 A BG 100510A BG 10051096 A BG10051096 A BG 10051096A BG 62756 B1 BG62756 B1 BG 62756B1
Authority
BG
Bulgaria
Prior art keywords
tablet according
treatment
androst
reductase
starch
Prior art date
Application number
BG100510A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG100510A (en
Inventor
Glenn Gormley
Keith Kaufman
Elizabeth Stoner
Joanne Waldstreicher
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26836279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG62756(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/214,905 external-priority patent/US5547957A/en
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of BG100510A publication Critical patent/BG100510A/xx
Publication of BG62756B1 publication Critical patent/BG62756B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG100510A 1993-10-15 1996-04-16 Метод за лечение на андрогенна алопеция с инхибитори на 5-алфа редуктаза BG62756B1 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13852093A 1993-10-15 1993-10-15
US08/214,905 US5547957A (en) 1993-10-15 1994-03-17 Method of treating androgenic alopecia with 5-α reductase inhibitors
PCT/US1994/011507 WO1995010284A1 (en) 1993-10-15 1994-10-11 Method of treating androgenic alopecia with 5-alpha reductase inhibitors

Publications (2)

Publication Number Publication Date
BG100510A BG100510A (en) 1996-11-29
BG62756B1 true BG62756B1 (bg) 2000-07-31

Family

ID=26836279

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100510A BG62756B1 (bg) 1993-10-15 1996-04-16 Метод за лечение на андрогенна алопеция с инхибитори на 5-алфа редуктаза

Country Status (28)

Country Link
US (3) US5824686A (es)
EP (1) EP0724444B1 (es)
JP (1) JP3058351B2 (es)
CN (1) CN1096861C (es)
AT (1) ATE156358T1 (es)
BG (1) BG62756B1 (es)
BR (1) BR9407824A (es)
CA (1) CA2173457C (es)
CY (1) CY2071B1 (es)
CZ (1) CZ287104B6 (es)
DE (1) DE69404854T2 (es)
DK (1) DK0724444T3 (es)
DZ (1) DZ1817A1 (es)
ES (1) ES2105774T3 (es)
FI (1) FI961632A (es)
GR (1) GR3024375T3 (es)
HR (1) HRP940673B1 (es)
HU (1) HU227861B1 (es)
IL (1) IL111293A (es)
LV (1) LV12103B (es)
MX (1) MXPA99002296A (es)
NO (1) NO309927B1 (es)
NZ (1) NZ275678A (es)
PL (1) PL184930B1 (es)
RO (1) RO116864B1 (es)
SK (1) SK282352B6 (es)
TW (1) TW382595B (es)
WO (1) WO1995010284A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547957A (en) * 1993-10-15 1996-08-20 Merck & Co., Inc. Method of treating androgenic alopecia with 5-α reductase inhibitors
NL1005445C2 (nl) * 1997-03-05 1998-09-21 Gho St Holding B V Werkwijze voor het vermenigvuldigen van haar.
US5935968A (en) 1997-03-17 1999-08-10 Merck & Co., Inc. Methods for treating polycystic ovary syndrome
ES2218840T3 (es) 1997-07-29 2004-11-16 Sankyo Company Limited Composicion azasteroide para ael tratamiento de la alopecia, el hirsutismo femenino y la seborrea.
US6348348B1 (en) * 1998-04-07 2002-02-19 The Carnegie Institution Of Washington Human hairless gene and protein
IL124764A0 (en) * 1998-06-04 1999-01-26 Univ Ben Gurion Topical composition for treatment of baldness
JP2002530332A (ja) 1998-11-20 2002-09-17 ザ ゼネラル ホスピタル コーポレーション 毛の成長を促進するためのピレスロイド化合物の使用
AU6087700A (en) * 1999-07-15 2001-02-05 Procter & Gamble Company, The Nitrogen-containing steroid compounds and their use to regulate hair growth
ES2158828B1 (es) * 2000-02-22 2002-03-16 Tobajas Maximo Gomez Metodo cosmetico para estimular el nacimiento y el crecimiento del cabello.
DE60027332D1 (de) * 2000-09-04 2006-05-24 Ravi Shrivastava Synergistische pflanzenmischung gegen haarausfall
DE60214080T2 (de) * 2001-05-31 2007-01-04 Pfizer Products Inc., Groton Medizinische Verwendung thyromimetischer Verbindungen gegen Haarausfall und Zusammensetzungen
US6645974B2 (en) 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof
BR0309435A (pt) 2002-04-24 2005-02-15 Boehringer Ingelheim Pharma Combinação farmacêutica para o tratamento de hiperplasia prostática benigna ou para a prevenção a longo prazo de retenção urinária aguda
FR2954124B1 (fr) * 2009-12-18 2012-04-06 Fabre Pierre Dermo Cosmetique Utilisation du 2,3-dihydroxypropyl dodecanoate pour le traitement de la seborrhee
KR20140003373A (ko) * 2010-08-05 2014-01-09 레가시 헬스케어 홀딩 리미티드 모발 성장 자극 방법
ES2647680T3 (es) * 2011-01-21 2017-12-26 Igisu Co., Ltd. Fármaco terapéutico para la alopecia
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic
EP2757881A4 (en) 2011-09-15 2014-11-12 Univ Kansas KAPPA OPIOID RECEPTOR EFFECTORS AND USES THEREOF
EP2703003A1 (en) 2012-08-31 2014-03-05 Probelte Biotecnologia S.L. A pomegranate extract and compositions containing pomegranate polyphenols for treating or preventing diseases or physiopathological conditions associated with an excessive gene expression and/or physiological activity of interleukin-6
PT3638198T (pt) * 2017-06-16 2021-11-18 Capilli Med Gmbh Composição para prevenir a queda do cabelo e promover o seu crescimento
US11331300B2 (en) * 2017-12-22 2022-05-17 Richard Postrel Reversing baldness through follicle regeneration
WO2020263115A1 (ru) 2019-06-28 2020-12-30 Общество С Ограниченной Ответственностью "Регеус" Средство для усиления роста волос
FR3106058B1 (fr) * 2020-01-09 2022-01-07 Oreal Procédé de traitement cosmétique
CN113398263B (zh) * 2021-08-06 2022-11-11 广东巧巧生物科技有限公司 一种治疗脱发的洗发水

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU527030B2 (en) * 1978-04-13 1983-02-10 Merck & Co., Inc. 4-aza-17-substituted-5a-androstan-3-ones
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4396615A (en) * 1981-06-24 1983-08-02 Duke University Method of treating androgen-related disorders
US4885289A (en) * 1983-12-12 1989-12-05 Breuer Miklos M Alteration of character of male beard growth
ZA851426B (en) 1984-02-27 1986-10-29 Merck & Co Inc 17 beta-n-monosubstituted carbamoyl-4-aza-5 alpha-androst-1-en-3-ones as 5 alpha reductase inhibitors
US5571817A (en) * 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
IL74365A (en) * 1984-02-27 1990-07-26 Merck & Co Inc 17beta-(n-t.-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one and pharmaceutical compositions containing it
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
US4684635A (en) * 1984-05-11 1987-08-04 Norman Orentreich Compositions and methods for inhibiting the action of androgens
US5053403A (en) * 1984-05-11 1991-10-01 Norman Orentreich Methods for treatment of male-pattern baldness
EP0285382B1 (en) * 1987-04-03 1994-04-13 Merck & Co. Inc. Treatment of androgenic alopecia with 17beta-n-monosubstituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones
US5228431A (en) * 1990-04-26 1993-07-20 Giarretto Ralph R Drug-free method for treatment of the scalp for therapeutic purposes
CA2085605C (en) * 1990-08-10 2003-03-11 Arthur Robert Diani Stimulation of hair growth with potassium channel openers and 5alpha-reductase inhibitors
US5175155A (en) * 1991-10-07 1992-12-29 Sterling Winthrop Inc. Win 49596-finasteride method of use and compositions
DE69329856D1 (de) * 1992-05-20 2001-02-15 Merck & Co Inc Ester derivate von 4-aza-steroiden
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
US5407944A (en) * 1993-02-19 1995-04-18 Goldman; Boris E. Compositions and methods for promoting hair growth
US5438061A (en) * 1993-07-16 1995-08-01 Merck & Co., Inc. 7-substituted-δ4-6-azasteroid derivatives as 5α-reductase inhibitors
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5547957A (en) * 1993-10-15 1996-08-20 Merck & Co., Inc. Method of treating androgenic alopecia with 5-α reductase inhibitors
US5708001A (en) * 1993-12-17 1998-01-13 Glaxo Wellcome Inc. Substituted 6-azaandrostenones
US5525608A (en) * 1994-04-20 1996-06-11 Merck & Co., Inc. 17b-aryl-4-aza-steroid derivatives useful as 5-alpha-reductase inhibitors
US5512555A (en) * 1994-07-21 1996-04-30 Merck & Co., Inc. Method of treating sweat-related conditions using finasteride, epristeride and a cholestan-3-one
US5595996A (en) * 1994-10-25 1997-01-21 Merck & Co., Inc. 7-substituted 4-aza cholanic acid derivatives and their use
US5777134A (en) * 1995-10-26 1998-07-07 Merck & Co., Inc. 4-oxa and 4-thia steriods
US5849764A (en) * 1995-12-14 1998-12-15 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
US5756507A (en) * 1995-12-14 1998-05-26 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
US5780437A (en) * 1995-12-14 1998-07-14 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone

Also Published As

Publication number Publication date
HU9600976D0 (en) 1996-06-28
NO961497D0 (no) 1996-04-15
US5824686A (en) 1998-10-20
CA2173457C (en) 1999-03-23
CN1096861C (zh) 2002-12-25
RO116864B1 (ro) 2001-07-30
ES2105774T3 (es) 1997-10-16
AU688395B2 (en) 1998-03-12
DZ1817A1 (fr) 2002-02-17
LV12103B (en) 1998-10-20
FI961632A0 (fi) 1996-04-12
HUT74426A (en) 1996-12-30
NZ275678A (en) 1999-09-29
HRP940673A2 (en) 1997-02-28
CA2173457A1 (en) 1995-04-20
HRP940673B1 (en) 2000-02-29
CZ108196A3 (en) 1996-08-14
GR3024375T3 (en) 1997-11-28
EP0724444B1 (en) 1997-08-06
CN1137237A (zh) 1996-12-04
DE69404854T2 (de) 1998-02-19
NO309927B1 (no) 2001-04-23
SK44896A3 (en) 1997-03-05
JP3058351B2 (ja) 2000-07-04
CY2071B1 (en) 1998-09-11
DK0724444T3 (da) 1997-09-15
EP0724444A1 (en) 1996-08-07
PL184930B1 (pl) 2003-01-31
TW382595B (en) 2000-02-21
LV12103A (lv) 1998-08-20
PL316854A1 (en) 1997-02-17
SK282352B6 (sk) 2002-01-07
HU227861B1 (en) 2012-05-02
US5981543A (en) 1999-11-09
BG100510A (en) 1996-11-29
CZ287104B6 (en) 2000-09-13
US5760046A (en) 1998-06-02
WO1995010284A1 (en) 1995-04-20
DE69404854D1 (de) 1997-09-11
AU7974294A (en) 1995-05-04
JPH09505034A (ja) 1997-05-20
NO961497L (no) 1996-04-15
MXPA99002296A (es) 2004-08-27
IL111293A (en) 1998-08-16
FI961632A (fi) 1996-04-12
ATE156358T1 (de) 1997-08-15
IL111293A0 (en) 1994-12-29
BR9407824A (pt) 1997-05-06

Similar Documents

Publication Publication Date Title
BG62756B1 (bg) Метод за лечение на андрогенна алопеция с инхибитори на 5-алфа редуктаза
US6355649B1 (en) Method of treating seborrhea with 5-α reductase inhibitors
AU2008323198B2 (en) C-19 steroids for cosmetic and further uses
JPH09504553A (ja) ５α−レダクターゼ阻害薬としての７−置換−４−アザ−ステロイド誘導体
CA2231434A1 (en) Method of preventing androgenetic alopecia with 5-.alpha. reductase inhibitors
EP0862556B1 (en) 17-alkyl-7-substituted-4-aza steroid derivatives
RU2173152C2 (ru) Способ лечения андрогенной алопеции ингибиторами 5-альфа-редуктазы
AU688395C (en) Method of treating androgenic alopecia with 5-alpha reductase inhibitors
CN117205216A (zh) 一种局部作用的雄激素受体拮抗剂与米诺地尔的组合物及其应用
CN117205148A (zh) 一种局部作用雄激素受体拮抗剂组合物及其应用
AU700565B2 (en) 5-alpha-reductase inhibitor formulations
SA94150323B1 (ar) طريقة لمعالجة الصلع الأندروجيني بواسطة مثبطات إنزيم 5- ألفا رداكتاز